- Home
- AIFF vs NXPL Comparison
AIFF vs NXPL Comparison
Compare AIFF & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIFF
- NXPL
- Stock Information
- Founded
- AIFF 2006
- NXPL 1997
- Country
- AIFF Canada
- NXPL United States
- Employees
- AIFF N/A
- NXPL N/A
- Industry
- AIFF
- NXPL Telecommunications Equipment
- Sector
- AIFF
- NXPL Telecommunications
- Exchange
- AIFF NYSE
- NXPL Nasdaq
- Market Cap
- AIFF 24.9M
- NXPL 21.9M
- IPO Year
- AIFF N/A
- NXPL N/A
- Fundamental
- Price
- AIFF $2.93
- NXPL $0.92
- Analyst Decision
- AIFF
- NXPL
- Analyst Count
- AIFF 0
- NXPL 0
- Target Price
- AIFF N/A
- NXPL N/A
- AVG Volume (30 Days)
- AIFF 65.7K
- NXPL 35.0K
- Earning Date
- AIFF 11-14-2024
- NXPL 11-14-2024
- Dividend Yield
- AIFF N/A
- NXPL N/A
- EPS Growth
- AIFF N/A
- NXPL N/A
- EPS
- AIFF N/A
- NXPL N/A
- Revenue
- AIFF $74,000.00
- NXPL $66,480,829.00
- Revenue This Year
- AIFF N/A
- NXPL N/A
- Revenue Next Year
- AIFF N/A
- NXPL N/A
- P/E Ratio
- AIFF N/A
- NXPL N/A
- Revenue Growth
- AIFF N/A
- NXPL 179.87
- 52 Week Low
- AIFF $2.74
- NXPL $0.75
- 52 Week High
- AIFF $15.90
- NXPL $2.68
- Technical
- Relative Strength Index (RSI)
- AIFF 42.66
- NXPL 36.88
- Support Level
- AIFF $2.92
- NXPL $0.82
- Resistance Level
- AIFF $3.36
- NXPL $1.06
- Average True Range (ATR)
- AIFF 0.34
- NXPL 0.10
- MACD
- AIFF -0.02
- NXPL -0.02
- Stochastic Oscillator
- AIFF 9.52
- NXPL 36.29
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.